A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
Clinical trial NCT01989754 · COMPLETED
Trial details
- NCT number
- NCT01989754
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-16
- Primary completion
- 2017-02-23
- Enrollment
- 5813
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.